Wed.Jul 22, 2020

article thumbnail

COVID-19 vaccine: A hope and prayer?

World of DTC Marketing

QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. We would like to think that any vaccine development will be within GMP and the drug approval process guidelines but when billions of dollars are at stake will the industry cut corners and who is going to be the watchdog? U.S. health officials agreed to pay $1.95 billion for 100 million doses of a vaccine made by Pfizer Inc. and BioNTech SE, the latest step in an effort to fi

article thumbnail

World Courier: COVID-19 impacting trial supply chain

Outsourcing Pharma

A leader from the specialty logistics firm discusses how the clinical researching industry is shifting, thanks in large part to the pandemic, and how to prepare for the future.

Trials 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Takeaways From Digital Pharma Week

Intouch Solutions

Last week, Fierce Life Sciences hosted a free, three-day virtual version of Digital Pharma Week. Check out some of the key takeaways here. The post Top Takeaways From Digital Pharma Week appeared first on Intouch Solutions.

article thumbnail

Marken doubles capacity of Frankfurt cold-chain facility

Outsourcing Pharma

The company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

How much is COVID-19 vaccine worth? $2bn per 100m doses

BioPharma Reporter

US government agrees a deal for 100m doses of potential vaccine, with option to take further 500m order.

article thumbnail

Ways IoT Has Transformed The Pulse Of Healthcare, And Will Continue To Do So In The Future

Delveinsight

The technology over the past few years has opened many new avenues and possibilities that have radically transformed the healthcare industry’s outlook. Today the tech-based healthcare industry is providing many unique solutions to the patient’s care which are more efficient and effective than the traditional services. The method of services delivery and design has transformed to the extent that people can access healthcare services from thousands of miles away with just a smartphone.

Doctors 59

More Trending

article thumbnail

DENGUE FEVER : A COMPLETE REVIEW

Pharma Tutor

About Author. SHIV KUMAR MANDAL*SHASHI DAKSH. Department of Pharmacy,Mewar University,Chittorgarh (312901), Rajasthan,India. shivmandal097@gmail.com. ABSTRACT. Dengue fever is the most common arthropod-borne self-limiting viral disease with clinical spectrum ranging from asymptomatic infection to life threatening shock. It is called as dengue shock syndrome.

article thumbnail

PwC’s Pharma & Life Sciences Hot Topics 2020

Pharma Business Blog

The year 2020 has seen a lot of development in the way we do business such as new regulations and smarter solutions to solve old and new challenges. PwC has identified the following hot topics for Pharma & Life Sciences which need our special attention: – Equal Salary – EU ATAD – Customs / Brexit / Trade Activator – Responsible Business / Moderate Immigration Initiatives – VAT and Clinical Trials / Commercial – Taxation of Digitalized Economy – COVID-19 Measures – SAP S/4HANA – DAC-6 – STAF

article thumbnail

Why Sponsors Should Consider Site Networks and the Truth About Clinical Studies at Research Sites

Clinical Trial Gurus

This video explains the role that site networks play in providing sponsors and CROs access to a variety of high quality and independently owned sites. These sites within the site network are able to reduce the impact of systematic errors which have been problematic in the past with SMOs. Additionally, site networks often reduce the overall time that is lost looking for quality sites and negotiating budgets.

article thumbnail

Can you get Promethazine Cough Syrup?

Druggist

Promethazine is an antihistamine commonly available in the UK pharmacies. With its sedative properties, promethazine can be used as sleeping aid product; however, it can also be used as an antihistamine for the treatment of allergic conditions including allergic rhinitis, itchiness of the skin and to help with mild anaphylactic reactions. In today’s post, I will discuss the availability of promethazine in the form of syrup.

Nurses 52
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

MaxCyte partners with Apeiron for siRNA immunotherapy

BioPharma Reporter

MaxCyte and Apeiron enter agreement for the use of engineering equipment for the development of a cell therapy.

article thumbnail

Updated extractables testing of PreVAS products

Syntegon Technology Pharma Blog

article thumbnail

MassBio wants improved manufacturing to maintain biohub position

BioPharma Reporter

The organization calls for capabilities to manufacture advanced therapeutics, such as cell and gene therapies.

article thumbnail

The growth of the UK’s ‘golden triangle’

BioPharma Reporter

Research outlines the pace of growth in the UKâs biohub and how it will progress towards 2050.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.